Combination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients with Benign Prostatic Hyperplasia

Although an increased level of the prostate-specific antigen can be an indication for prostate cancer, other reasons often lead to a high rate of false positive results. Therefore, an additional serological screening of autoantibodies in patients’ sera could improve the detection of prostate cancer....

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Leidinger, Petra, Keller, Andreas, Milchram, Lisa, Harz, Christian, Hart, Martin, Werth, Angelika, Lenhof, Hans-Peter, Weinhäusel, Andreas, Keck, Bastian, Wullich, Bernd, Ludwig, Nicole, Meese, Eckart
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2015
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4454546/
https://ncbi.nlm.nih.gov/pubmed/26039628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0128235
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires